US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist

5.090
+0.150+3.04%

Close Nov 22 16:00 ET

5.010
-0.080-1.57%

Post 20:01 ET

296.79MMarket Cap-17551P/E (TTM)

Vanda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

22.76%47.65M

9.59%50.47M

-24.06%47.46M

-24.27%192.64M

-29.79%45.27M

-40.58%38.82M

-28.47%46.06M

3.83%62.5M

-5.32%254.38M

-5.20%64.48M

Operating revenue

22.76%47.65M

9.59%50.47M

-24.06%47.46M

-24.27%192.64M

-29.79%45.27M

-40.58%38.82M

-28.47%46.06M

3.83%62.5M

-5.32%254.38M

-5.20%64.48M

Cost of revenue

-16.72%2.55M

-21.89%2.73M

-27.94%3.44M

-39.07%14.8M

-44.53%3.46M

-51.53%3.06M

-42.25%3.5M

-15.73%4.77M

-5.26%24.28M

0.03%6.24M

Gross profit

26.15%45.1M

12.18%47.74M

-23.74%44.02M

-22.71%177.84M

-28.21%41.81M

-39.40%35.75M

-27.04%42.56M

5.86%57.72M

-5.33%230.1M

-5.73%58.24M

Operating expense

34.38%56.1M

27.44%57.89M

-4.42%53.26M

-14.29%191.8M

-5.25%48.91M

-24.22%41.75M

-17.22%45.42M

-10.41%55.72M

11.39%223.77M

-2.88%51.62M

Selling and administrative expenses

51.71%37.57M

39.00%39.47M

-16.67%30.09M

-17.29%112.88M

-27.97%23.61M

-17.04%24.77M

-13.95%28.4M

-11.61%36.1M

10.03%136.49M

-1.99%32.78M

Research and development costs

1.06%16.78M

0.08%16.66M

9.97%21.15M

-10.43%76.82M

31.89%24.34M

-33.22%16.6M

-22.54%16.65M

-8.26%19.24M

13.81%85.77M

-4.54%18.45M

Depreciation amortization depletion

360.79%1.75M

363.49%1.75M

432.45%2.02M

37.86%2.09M

151.45%953K

0.26%380K

-0.26%378K

0.00%379K

2.57%1.52M

2.71%379K

-Depreciation and amortization

360.79%1.75M

363.49%1.75M

432.45%2.02M

37.86%2.09M

151.45%953K

0.26%380K

-0.26%378K

0.00%379K

2.57%1.52M

2.71%379K

Operating profit

-83.49%-11M

-253.89%-10.15M

-560.83%-9.24M

-320.45%-13.95M

-207.01%-7.09M

-253.40%-6M

-182.84%-2.87M

126.13%2M

-84.99%6.33M

-23.24%6.63M

Net non-operating interest income expense

Other net income (expense)

-19.05%4.76M

-15.19%4.63M

29.71%4.57M

308.19%20.29M

82.07%5.43M

278.30%5.88M

1,559.27%5.46M

3,256.19%3.52M

2,397.99%4.97M

11,576.92%2.98M

Other non- operating income (expenses)

-19.05%4.76M

-15.19%4.63M

29.71%4.57M

308.19%20.29M

82.07%5.43M

278.30%5.88M

1,559.27%5.46M

3,256.19%3.52M

2,397.99%4.97M

11,576.92%2.98M

Income before tax

-5,103.33%-6.24M

-312.81%-5.52M

-184.37%-4.66M

-43.90%6.34M

-117.28%-1.66M

-102.20%-120K

-31.61%2.59M

173.08%5.53M

-73.33%11.3M

11.65%9.61M

Income tax

-257.98%-920K

-193.10%-998K

-122.76%-518K

-23.78%3.83M

-73.15%739K

-111.73%-257K

-11.84%1.07M

300.71%2.28M

-45.45%5.03M

79.63%2.75M

Net income

-3,986.13%-5.32M

-397.24%-4.52M

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

Net income continuous Operations

-3,986.13%-5.32M

-397.24%-4.52M

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

Minority interest income

Net income attributable to the parent company

-3,986.13%-5.32M

-397.24%-4.52M

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-3,986.13%-5.32M

-397.24%-4.52M

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

Basic earnings per share

-3,878.34%-0.09

-366.67%-0.08

-216.67%-0.07

-63.64%0.04

-133.33%-0.04

-96.03%0.0024

-40.00%0.03

154.55%0.06

-81.67%0.11

-7.69%0.12

Diluted earnings per share

-3,883.10%-0.09

-366.67%-0.08

-216.67%-0.07

-63.64%0.04

-133.33%-0.04

-96.04%0.0024

-40.00%0.03

154.55%0.06

-81.03%0.11

0.00%0.12

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	22.76%47.65M	9.59%50.47M	-24.06%47.46M	-24.27%192.64M	-29.79%45.27M	-40.58%38.82M	-28.47%46.06M	3.83%62.5M	-5.32%254.38M	-5.20%64.48M
Operating revenue	22.76%47.65M	9.59%50.47M	-24.06%47.46M	-24.27%192.64M	-29.79%45.27M	-40.58%38.82M	-28.47%46.06M	3.83%62.5M	-5.32%254.38M	-5.20%64.48M
Cost of revenue	-16.72%2.55M	-21.89%2.73M	-27.94%3.44M	-39.07%14.8M	-44.53%3.46M	-51.53%3.06M	-42.25%3.5M	-15.73%4.77M	-5.26%24.28M	0.03%6.24M
Gross profit	26.15%45.1M	12.18%47.74M	-23.74%44.02M	-22.71%177.84M	-28.21%41.81M	-39.40%35.75M	-27.04%42.56M	5.86%57.72M	-5.33%230.1M	-5.73%58.24M
Operating expense	34.38%56.1M	27.44%57.89M	-4.42%53.26M	-14.29%191.8M	-5.25%48.91M	-24.22%41.75M	-17.22%45.42M	-10.41%55.72M	11.39%223.77M	-2.88%51.62M
Selling and administrative expenses	51.71%37.57M	39.00%39.47M	-16.67%30.09M	-17.29%112.88M	-27.97%23.61M	-17.04%24.77M	-13.95%28.4M	-11.61%36.1M	10.03%136.49M	-1.99%32.78M
Research and development costs	1.06%16.78M	0.08%16.66M	9.97%21.15M	-10.43%76.82M	31.89%24.34M	-33.22%16.6M	-22.54%16.65M	-8.26%19.24M	13.81%85.77M	-4.54%18.45M
Depreciation amortization depletion	360.79%1.75M	363.49%1.75M	432.45%2.02M	37.86%2.09M	151.45%953K	0.26%380K	-0.26%378K	0.00%379K	2.57%1.52M	2.71%379K
-Depreciation and amortization	360.79%1.75M	363.49%1.75M	432.45%2.02M	37.86%2.09M	151.45%953K	0.26%380K	-0.26%378K	0.00%379K	2.57%1.52M	2.71%379K
Operating profit	-83.49%-11M	-253.89%-10.15M	-560.83%-9.24M	-320.45%-13.95M	-207.01%-7.09M	-253.40%-6M	-182.84%-2.87M	126.13%2M	-84.99%6.33M	-23.24%6.63M
Net non-operating interest income expense
Other net income (expense)	-19.05%4.76M	-15.19%4.63M	29.71%4.57M	308.19%20.29M	82.07%5.43M	278.30%5.88M	1,559.27%5.46M	3,256.19%3.52M	2,397.99%4.97M	11,576.92%2.98M
Other non- operating income (expenses)	-19.05%4.76M	-15.19%4.63M	29.71%4.57M	308.19%20.29M	82.07%5.43M	278.30%5.88M	1,559.27%5.46M	3,256.19%3.52M	2,397.99%4.97M	11,576.92%2.98M
Income before tax	-5,103.33%-6.24M	-312.81%-5.52M	-184.37%-4.66M	-43.90%6.34M	-117.28%-1.66M	-102.20%-120K	-31.61%2.59M	173.08%5.53M	-73.33%11.3M	11.65%9.61M
Income tax	-257.98%-920K	-193.10%-998K	-122.76%-518K	-23.78%3.83M	-73.15%739K	-111.73%-257K	-11.84%1.07M	300.71%2.28M	-45.45%5.03M	79.63%2.75M
Net income	-3,986.13%-5.32M	-397.24%-4.52M	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M
Net income continuous Operations	-3,986.13%-5.32M	-397.24%-4.52M	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M
Minority interest income
Net income attributable to the parent company	-3,986.13%-5.32M	-397.24%-4.52M	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-3,986.13%-5.32M	-397.24%-4.52M	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M
Basic earnings per share	-3,878.34%-0.09	-366.67%-0.08	-216.67%-0.07	-63.64%0.04	-133.33%-0.04	-96.03%0.0024	-40.00%0.03	154.55%0.06	-81.67%0.11	-7.69%0.12
Diluted earnings per share	-3,883.10%-0.09	-366.67%-0.08	-216.67%-0.07	-63.64%0.04	-133.33%-0.04	-96.04%0.0024	-40.00%0.03	154.55%0.06	-81.03%0.11	0.00%0.12
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data